サマリー

AEAサリチル酸市場は、2020年に2億7450万ドル、2030年には5億5380万ドルに達し、2020年から2030年まで年平均成長率7.3％で成長すると予測されています。
サリチル酸は、親油性のモノヒドロキシ安息香酸で、フェノール酸の一種であり、分子式C₇H₆O₃のβヒドロキシ酸である。物性的には、無臭、無色の結晶性有機酸である。サリチル酸は、医薬品やパーソナルケア産業の中間体として作用します。AEAサリチル酸市場の推定には、サリチル酸とその用途によって報告された収益が含まれています。
サリチル酸の抗炎症特性のために、それは非常に医薬品およびスキンケア産業によって好まれています。したがって、AEAサリチル酸市場は、医薬品、食品＆飲料、化粧品＆パーソナルケア業界などの様々な最終使用産業からの需要の増加のために、予測期間中に強力な成長の機会を目撃すると予想されます。さらに、サリチル酸はアスピリンの製造に欠かせない成分です。アスピリンは世界で最も処方頻度の高い医薬品の一つであり、優れた鎮痛作用と入手のしやすさから、その使用量は増加傾向にあります。また、高齢者を中心に認知症や脳卒中などの病気の予防や治療にも使用されることが多くなっており、このことがこの医薬品の需要を後押ししています。

さらに、サリチル酸はその酸化作用により、パーソナルケアおよび化粧品産業で使用されています。ニキビ、白斑、黒ずみ、イボ、ニキビに悩む人の増加が、サリチル酸ベースの化粧品の需要をさらに押し上げると予想されます。さらに、パーソナルケア製品の開発が、予測期間中のサリチル酸市場の成長をサポートすると予想されます。

ステークホルダーにとっての主なメリット
本レポートでは、現在のトレンドと2021年から2030年までの市場の将来予測を定性・定量的に幅広く分析し、有力なビジネスチャンスを判断します。
市場の成長を促進および制限する要因について包括的な分析を提供しています。
ポーターのファイブフォース分析により、バイヤー＆サプライヤーの潜在力と業界の競争シナリオを分析し、戦略構築に役立てます。
競争シナリオを理解するために、市場で活動する主要企業のプロフィールを提供しています。
本レポートでは、良好な成長を示している重要なセグメントと地域に関する広範な定性的洞察を提供しています。
主な市場セグメント
用途別
- 医薬品
- スキンケア
- ヘアケア
- 食品保存料、その他


地域別
- 北アメリカ
o 米国
o カナダ
o メキシコ
- ラテンアメリカ
o ブラジル
o アルゼンチン
o チリ
o その他のラテンアメリカ地域
- 欧州
o フランス
o ドイツ
o イタリア
o スペイン
o イギリス
o その他のヨーロッパ
- アフリカ
o アルジェリア
o エジプト
o モロッコ
o その他のアフリカ地域
主な市場関係者
- Alfa Aesar社
- アボンケム社
- J.M.ロベリッジ社
- ノバシル
- ミダスファーマGmbH
- ウェゴケミカルグループ
- ソルベイ
- メルクKGaA
- 試薬
その他、Thermo Fisher Scientific社、Alta Laboratories社などがあります。

ページTOPに戻る

目次

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research

1.5.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Surge in demand from preserved food & beverage industry
3.4.1.2.Increase in demand for personal care products

3.4.2.Restraint

3.4.2.1.Consumer awareness about harmful effects

3.4.3.Opportunities

3.4.3.1.High adoption of salicylic acid in pharmaceuticals and cosmetics
3.4.3.2.Rise in demand for aspirin drug

3.5.Value chain analysis
3.6.Patent analysis

3.6.1.Patent analysis by country

3.7.Value chain players
3.8.Pricing analysis
3.9.Salicylic acid derivative outlook (salicylates)

3.9.1.U.S.
3.9.2.Canada
3.9.3.Germany
3.9.4.UK

3.10.Salicylic acid derivatives
3.11.Impact of COVID-19 outbreak on the salicylic acid market

CHAPTER 4:AEA SALICYLIC ACID MARKET, BY APPLICATION

4.1.Overview

4.1.1.Market size and forecast, by region

4.2.Pharmaceutical

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Skin care

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Haircare

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

4.5.Food preservative & others

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

CHAPTER 5:AEA SALICYLIC ACID MARKET, BY REGION

5.1.Overview

5.1.1.Market size and forecast, by region

5.2.North America

5.2.1.Key market trends, growth factors, and opportunity
5.2.2.Market Size and Forecast
5.2.3.Market size and forecast, by country

5.2.3.1.U.S.

5.2.3.1.1.Market size and forecast, by application

5.2.3.2.Canada

5.2.3.2.1.Market size and forecast, by application

5.2.3.3.Mexico

5.2.3.3.1.Market size and forecast, by application

5.3.Latin America

5.3.1.Key market trends, growth factors, and opportunity
5.3.2.Market Size and Forecast
5.3.3.Market size and forecast, by country

5.3.3.1.Brazil

5.3.3.1.1.Market size and forecast, by application

5.3.3.2.Argentina

5.3.3.2.1.Market size and forecast, by application

5.3.3.3.Chile

5.3.3.3.1.Market size and forecast, by application

5.3.3.4.Rest of Latin America

5.3.3.4.1.Market size and forecast, by application

5.4.Europe

5.4.1.Key market trends, growth factors, and opportunity
5.4.2.Market Size and Forecast
5.4.3.Market size and forecast, by country

5.4.3.1.France

5.4.3.1.1.Market size and forecast, by application

5.4.3.2.Germany

5.4.3.2.1.Market size and forecast, by application

5.4.3.3.Italy

5.4.3.3.1.Market size and forecast, by application

5.4.3.4.Spain

5.4.3.4.1.Market size and forecast, by application

5.4.3.5.UK

5.4.3.5.1.Market size and forecast, by application

5.4.3.6.Rest of Europe

5.4.3.6.1.Market size and forecast, by application

5.5.Africa

5.5.1.Key market trends, growth factors, and opportunity
5.5.2.Market Size and Forecast
5.5.3.Market size and forecast, by country

5.5.3.1.Algeria

5.5.3.1.1.Market size and forecast, by application

5.5.3.2.Egypt

5.5.3.2.1.Market size and forecast, by application

5.5.3.3.Morocco

5.5.3.3.1.Market size and forecast, by application

5.5.3.4.Rest of Africa

5.5.3.4.1.Market size and forecast, by application

CHAPTER 6:COMPETITIVE LANDSCAPE

6.1.Introduction

6.1.1.Market player positioning

6.2.Competitive heatmap
6.3.Key developments

6.3.1.Business expansion
6.3.2.Expansions

CHAPTER 7:COMPANY PROFILES

7.1.ALFA AESAR

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio

7.2.AVONCHEM LIMITED

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio

7.3.J.M. LOVERIDGE LTD.

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segment
7.3.4.Product portfolio

7.4.NOVACYL

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Key strategic moves and developments

7.5.MIDAS PHARMA GmbH

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio

7.6.WEGO CHEMICAL GROUP

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Product portfolio

7.7.LARACHEM INC.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Product portfolio

7.8.MERCK KGAA

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Research and development
7.8.6.Business performance

7.9.REAGENTS

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Product portfolio

7.10.SOLVAY

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Research and development
7.10.6.Business performance


List of Tables

LIST OF TABLES

TABLE 01.LIST OFVALUE CHAIN PLAYERS
TABLE 02.LIST OF SALICYLIC ACID DERIVATIVES
TABLE 03.AEA SALICYLIC ACID MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 04.AEA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 05.AEA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 06.AEA SALICYLIC ACID MARKET FOR PHARMACEUTICAL, BY REGION, 2020–2030 (TON)
TABLE 07.AEA SALICYLIC ACID MARKET FOR PHARMACEUTICAL, BY REGION,2020–2030 ($MILLION)
TABLE 08.AEA SALICYLIC ACID MARKET FOR SKIN CARE, BY REGION,2020–2030 (TON)
TABLE 09.AEA SALICYLIC ACID MARKET FOR SKIN CARE, BY REGION,2020–2030 ($MILLION)
TABLE 10.AEA SALICYLIC ACID MARKET FOR HAIRCARE, BY REGION,2020–2030 (TON)
TABLE 11.AEA SALICYLIC ACID MARKET FOR HAIRCARE, BY REGION,2020–2030 ($MILLION)
TABLE 12.SALICYLIC ACID MARKET FOR FOOD PRESERVATIVE & OTHERS, BY REGION, 2020–2030 (TON)
TABLE 13.SALICYLIC ACID MARKET FOR FOOD PRESERVATIVE & OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 14.AEA SALICYLIC ACID MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
TABLE 15.AEA SALICYLIC ACID MARKET, BY REGION, 2020–2030 (TON)
TABLE 16.AEA SALICYLIC ACID MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 18.NORTH AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 19.NORTH AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 20.NORTH AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 21.U.S. SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 22.U.S. SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 23.CANADA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 24.CANADA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 25.MEXICO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 26.MEXICO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 27.LATIN AMERICASALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 28.LATIN AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 29.LATIN AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 30.LATIN AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 31.BRAZIL SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 32.BRAZIL SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 33.ARGENTINA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 34.ARGENTINA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35.CHILE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 36.CHILE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 37.REST OF LATIN AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 38.REST OF LATIN AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 39.EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 40.EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 41.EUROPE SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 42.EUROPE SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 43.FRANCE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 44.FRANCE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 45.GERMANY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 46.GERMANY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 47.ITALY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 48.ITALY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 49.SPAIN SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 50.SPAIN SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 51.UK SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 52.UK SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 53.REST OF EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 54.REST OF EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 55.AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 56.AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 57.AFRICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 58.AFRICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 59.ALGERIA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 60.ALGERIA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 61.EGYPT SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 62.EGYPT SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 63.MOROCCO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 64.MOROCCO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 65.REST OF AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 66.REST OF AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 67.KEY EXPANSIONS
TABLE 68.ALFA: COMPANY SNAPSHOT
TABLE 69.ALFA: OPERATING SEGMENTS
TABLE 70.ALFA: PRODUCT PORTFOLIO
TABLE 71.AVONCHEM: COMPANY SNAPSHOT
TABLE 72.AVONCHEM: OPERATING SEGMENTS
TABLE 73.AVONCHEM: PRODUCT PORTFOLIO
TABLE 74.J.M. LOVERIDGE: COMPANY SNAPSHOT
TABLE 75.J.M. LOVERIDGE: OPERATING SEGMENT
TABLE 76.J.M. LOVERDIGE: PRODUCT PORTFOLIO
TABLE 77.NOVACYL: COMPANY SNAPSHOT
TABLE 78.NOVACYL: OPERATING SEGMENTS
TABLE 79.NOVACYL: PRODUCT PORTFOLIO
TABLE 80.NOVACYL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 81.MIDAS PHARMA: COMPANY SNAPSHOT
TABLE 82.MIDAS PHARMA: OPERATING SEGMENTS
TABLE 83.MIDAS PHARMA: PRODUCT PORTFOLIO
TABLE 84.WEGO: COMPANY SNAPSHOT
TABLE 85.WEGO: PRODUCT PORTFOLIO
TABLE 86.LARACHEM INC.: COMPANY SNAPSHOT
TABLE 87.LARACHEM INC.: PRODUCT PORTFOLIO
TABLE 88.MERCK: COMPANY SNAPSHOT
TABLE 89.MERCK: OPERATING SEGMENTS
TABLE 90.MERCK: PRODUCT PORTFOLIO
TABLE 91.MERCK: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 92.MERCK: NET SALES, 2018–2020 ($MILLION)
TABLE 93.REAGENTS: COMPANY SNAPSHOT
TABLE 94.REAGENTS: PRODUCT PORTFOLIO
TABLE 95.SOLVAY: COMPANY SNAPSHOT
TABLE 96.SOLVAY: OPERATING SEGMENTS
TABLE 97.SOLVAY: PRODUCT PORTFOLIO
TABLE 98.SOLVAY: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 99.SOLVAY: NET SALES, 2018–2020 ($MILLION)


List of Figures

LIST OF FIGURES

FIGURE 01.AEA SALICYLIC ACID MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS, BY COUNTRY
FIGURE 03.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 04.HIGH BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE THREAT OF NEW ENTRANTS
FIGURE 06.MODERATE THREAT OF SUBSTITUTES
FIGURE 07.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 08.AEA SALICYLIC ACID MARKET DYNAMICS
FIGURE 09.PATENT ANALYSIS, BY COUNTRY
FIGURE 10.PATENT ANALYSIS, BY APPLICANT
FIGURE 11.PATENT ANALYSIS, BY INVENTOR
FIGURE 12.SALICYLIC ACID PRICING ANALYSIS, BY REGION, (2020-2030)
FIGURE 13.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 14.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 15.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 16.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 17.COMPARATIVE ANALYSIS OF AEA SALICYLIC ACID MARKET FOR PHARMACEEUTICAL, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF AEA SALICYLIC ACID MARKET FOR SKIN CARE, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF AEA SALICYLIC ACID MARKET FOR HAIRCARE, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF SALICYLIC ACID MARKET FOR FOOD PRESERVATIVE & OTHERS, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 21.U.S. SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 22.CANADA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 23.MEXICO SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 24.BRAZIL SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 25.ARGENTINA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 26.CHILE SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 27.REST OF LATIN AMERICA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 28.FRANCE SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 29.GERMANY SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 30.ITALY SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 31.SPAIN SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 32.UK SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 33.REST OF EUROPE SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 34.ALGERIA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 35.EGYPT SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 36.MOROCCO SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 37.REST OF AFRICA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 38.MARKET PLAYER POSITIONING
FIGURE 39.COMPETITIVE HEATMAP OF KEY PLAYERS
FIGURE 40.MERCK: R&D, 2018–2020 ($MILLION)
FIGURE 41.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.MERCK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 44.SOLVAY: R&D, 2018–2020 ($MILLION)
FIGURE 45.SOLVAY: NET SALES, 2018–2020 ($MILLION)
FIGURE 46.SOLVAY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47.SOLVAY: REVENUE SHARE BY REGION, 2020 (%)